RxDoctor Payments Data

Christopher Happ, DO

Orthopaedic Surgery of the Spine · Weatherford, TXNPI 1154561702

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $88,863 of the $104,749 with a category attached, or 84.8%. Nvision Biomedical Technologies, Inc. accounts for 89.6% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2023 at $30,906 and has fallen 98.4% since, to $508 in 2025.

$104,749in general payments, 2019–2025

Across 90 payments — averaging $1163.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nvision Biomedical Technologies, Inc.$94K
  • Kyocera Medical Technologies, Inc.$4K
  • Nanohive Medical LLC$3K
  • Centinel Spine, LLC$1K
  • Nevro Corp.$866
  • Camber Spine Technologies LLC$613
  • plus $1K from 15 others

What the payments were for

  • Royalty or licence$88,86385%
  • Consulting fees$11,10411%
  • Travel & lodging$1,5501%
  • Food & beverage$3,2333%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$104,749 in reported general payments places this provider in the 75th percentile of 207 orthopaedic surgery of the spine providers in Texas.

See all orthopaedic surgery of the spine providers in Texas

Medicare billing

Part B allowed, 2024
$236,063
Medicare patients
415
Services billed
985

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib340$11,544
Tizanidine Hcl465$6,667
Gabapentin237$3,028
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen71$2,082
Etodolac67$1,671
Methocarbamol102$1,464
Pregabalin68$1,018
Cyclobenzaprine Hcl37$867
Acetaminophen-CodeineAcetaminophen With Codeine16$508
Cephalexin48$205
Prednisone85$195
Tramadol Hcl23$139
Meloxicam25$83

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Weatherford

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →